Diabetes Mellitus, Type 1

Showing NaN - NaN of 42

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Diabetes, Type 1 Trial in Worldwide (Empagliflozin, Placebo)

Completed
  • Diabetes Mellitus, Type 1
  • Montgomery, Alabama
  • +188 more
Oct 31, 2018

Celiac Disease, Diabetes, Type 1 Trial in Canada (Gluten Free Diet)

Completed
  • Celiac Disease
  • Diabetes Mellitus, Type 1
  • Gluten Free Diet
  • Hamilton, Ontario, Canada
  • +6 more
Sep 4, 2018

Diabetes, Type 1 Trial in Worldwide (otelixizumab infusion plus physician determined standard of care, infusion plus physician

Completed
  • Diabetes Mellitus, Type 1
  • otelixizumab infusion plus physician determined standard of care
  • placebo infusion plus physician determined standard of care
  • Birmingham, Alabama
  • +108 more
Sep 5, 2017

Diabetes, Type 1 Trial in Worldwide (Insulin detemir, NPH insulin)

Completed
  • Diabetes Mellitus, Type 1
  • Insulin detemir
  • NPH insulin
  • Broadmeadow, New South Wales, Australia
  • +92 more
Jul 17, 2017

Diabetes, Diabetes, Type 1 Trial in Worldwide (liraglutide, )

Terminated
  • Diabetes
  • Diabetes Mellitus, Type 1
  • Duarte, California
  • +15 more
Feb 28, 2017

Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin detemir, NPH insulin, insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 1
  • insulin detemir
  • +2 more
  • Buenos Aires, Argentina
  • +99 more
Jan 30, 2017

Diabetes, Diabetes, Type 1 Trial in Worldwide (liraglutide, )

Completed
  • Diabetes
  • Diabetes Mellitus, Type 1
  • Little Rock, Arkansas
  • +181 more
Jan 16, 2017

Diabetes, Diabetes, Type 1, Glucose Metabolism Disorders Trial in Cambridge, Leeds, London (Overnight closed-loop, Real-time CGM

Completed
  • Diabetes Mellitus
  • +4 more
  • Overnight closed-loop
  • Real-time CGM alone
  • Cambridge, United Kingdom
  • +2 more
Feb 28, 2017

Diabetes, Diabetes, Type 1 Trial in Worldwide (insulin aspart, human soluble insulin, insulin NPH)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 1
  • insulin aspart
  • +2 more
  • Graz, Austria
  • +79 more
Jan 3, 2017

Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in Worldwide (biphasic insulin aspart 50, biphasic insulin aspart 70,

Completed
  • Diabetes
  • +2 more
  • biphasic insulin aspart 50
  • +2 more
  • Aalst, Belgium
  • +76 more
Jan 3, 2017

Diabetes, Diabetes, Type 1 Trial in Worldwide (human insulin, insulin aspart)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 1
  • human insulin
  • insulin aspart
  • Ciudad de Buenos Aires, Argentina
  • +94 more
Dec 20, 2016

Safety of LevemirĀ® in Patients With Diabetes

Completed
  • Diabetes
  • +2 more
  • insulin detemir
  • Dublin, Ireland
  • +1 more
Oct 27, 2016

Diabetes, Type 1 Trial in Canada, United States (Canagliflozin 100 mg, Canagliflozin 300 mg, Placebo)

Completed
  • Diabetes Mellitus, Type 1
  • Canagliflozin 100 mg
  • +2 more
  • Little Rock, Arkansas
  • +52 more
Jun 7, 2016

Diabetes, Type 1, Diabetes, Type 2, Asthma Trial in Worldwide (Technosphere Insulin)

Terminated
  • Diabetes Mellitus, Type 1
  • +2 more
  • Technosphere Insulin
  • Phoenix, Arizona
  • +77 more
May 3, 2012

Diabetes, Type 1 Trial in United Kingdom (X54 insulin pump with low suspend feature)

Completed
  • Diabetes Mellitus, Type 1
  • X54 insulin pump with low suspend feature
  • Cambridge, Cambridgeshire, United Kingdom
  • +5 more
Feb 16, 2011

Diabetes, Type 1 Trial in Worldwide (Subcutaneous Insulin, Inhaled Insulin)

Terminated
  • Diabetes Mellitus, Type 1
  • Subcutaneous Insulin
  • Inhaled Insulin
  • Fullerton, California
  • +72 more
Feb 3, 2010

Diabetes, Type 1 Trial in Canada, United States (Inhaled human insulin)

Completed
  • Diabetes Mellitus, Type 1
  • Inhaled human insulin
  • Burlingame, California
  • +36 more
Feb 9, 2007